Depletion of RNA-binding protein RBM8A (Y14) causes cell cycle deficiency and apoptosis in human cells

Experimental Biology and Medicine

Volumn 238, Issue 8, 2013, Pages 889-897

  Ishigaki, Yasuhito ^a   Nakamura, Yuka ^a   Tatsuno, Takanori ^a   Hashimoto, Mitsumasa ^a   Shimasaki, Takeo ^a   Iwabuchi, Kuniyoshi ^a   Tomosugi, Naohisa ^a,b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b MCProt Biotechnology Co Ltd   (Japan)

Author keywords

apoptosis; cell cycle; G2 M phase; Magoh; RBM8A (Y14)

Indexed keywords

APOPTOSIS; CELL CYCLE; G2/M PHASE; MAGOH; RBM8A (Y14);

ADENOCARCINOMA; APOPTOSIS; CASPASES; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELLS, CULTURED; CENTROSOME; DOWN-REGULATION; FEMALE; G1 PHASE; GENE SILENCING; HELA CELLS; HUMANS; LUNG NEOPLASMS; NUCLEAR PROTEINS; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS;

EID: 84883785512     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213494646     Document Type: Article

References (31)

1. Le Hir H,Gatfield D,Izaurralde E,Moore MJ.The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay.Embo J. 2001;20:4987-97.
2. Kim VN,Kataoka N,Dreyfuss G.Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon-exon junction complex.Science. 2001;293:1832-6.
3. Kim VN,Yong J,Kataoka N,Abel L,Diem MD,Dreyfuss G.The Y14 protein communicates to the cytoplasm the position of exon-exon junctions.Embo J. 2001;20:2062-8.
4. Dostie J,Dreyfuss G.Translation is required to remove Y14 from mRNAs in the cytoplasm.Curr Biol. 2002;12:1060-7.
5. Bono F,Ebert J,Unterholzner L,Guttler T,Izaurralde E,Conti E.Molecular insights into the interaction of PYM with the Mago-Y14 core of the exon junction complex.Embo Rep. 2004;5:304-10.
6. Gehring NH,Lamprinaki S,Hentze MW,Kulozik AE.The hierarchy of exon-junction complex assembly by the spliceosome explains key features of mammalian nonsense-mediated mRNA decay.PLoS Biol. 2009;7:e1000120-e1000120.
7. Muromoto R,Taira N,Ikeda O,Shiga K,Kamitani S,Togi S,Kawakami S,Sekine Y,Nanbo A,Oritani K,Matsuda T.The exon-junction complex proteins, Y14 and MAGOH regulate STAT3 activation.Biochem Biophys Res Commun. 2009;382:63-8.
8. Ohbayashi N,Taira N,Kawakami S,Togi S,Sato N,Ikeda O,Kamitani S,Muromoto R,Sekine Y,Matsuda T.An RNA biding protein, Y14 interacts with and modulates STAT3 activation.Biochem Biophys Res Commun. 2008;372:475-9.
9. Sudo H,Tsuji AB,Sugyo A,Kohda M,Sogawa C,Yoshida C,Harada YN,Hino O,Saga T.Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model.Genomics. 2010;95:210-6.
10. Silver DL,Watkins-Chow DE,Schreck KC,Pierfelice TJ,Larson DM,Burnetti AJ,Liaw H-J,Myung K,Walsh CA,Gaiano N,Pavan WJ.The exon junction complex component Magoh controls brain size by regulating neural stem cell division.Nat Neurosci. 2010;13:551-8.
11. Inaki M,Kato D,Utsugi T,Onoda F,Hanaoka F,Murakami Y.Genetic analyses using a mouse cell cycle mutant identifies magoh as a novel gene involved in Cdk regulation.Genes Cells. 2011;16:166-78.
12. Albers CA,Paul DS,Schulze H,Freson K,Stephens JC,Smethurst PA,Jolley JD,Cvejic A,Kostadima M,Bertone P,Breuning MH,Debili N,Deloukas P,Favier R,Fiedler J,Hobbs CM,Huang N,Hurles ME,Kiddle G,Krapels I,Nurden P,Ruivenkamp CAL,Sambrook JG,Smith K,Stemple DL,Strauss G,Thys C,van Geet C,Newbury-Ecob R,Ouwehand WH,Ghevaert C.Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome.Nat Genet. 2012;44:435-9, S1-2.
13. Conklin DC,Rixon MW,Kuestner RE,Maurer MF,Whitmore TE,Millar RP.Cloning and gene expression of a novel human ribonucleoprotein.Biochim Biophys Acta. 2000;1492:465-9.
14. Okubo K,Mitani H,Naruse K,Kondo M,Shima A,Tanaka M,Aida K.Conserved physical linkage of GnRH-R and RBM8 in the medaka and human genomes.Biochem Biophys Res Commun. 2002;293:327-31.
15. Nagao A,Zhao X,Takegami T,Nakagawa H,Matsui S,Matsunaga T,Ishigaki Y.Multiple shRNA expressions in a single plasmid vector improve RNAi against the XPA gene.Biochem Biophys Res Commun. 2008;370:301-5.
16. Ishigaki Y,Nakamura Y,Takehara T,Shimasaki T,Tatsuno T,Takano F,Ueda Y,Motoo Y,Takegami T,Nakagawa H,Kuwabata S,Nemoto N,Tomosugi N,Miyazawa S.Scanning electron microscopy with an ionic liquid reveals the loss of mitotic protrusions of cells during the epithelial-mesenchymal transition.Microsc Res Tech. 2011;74:1024-31.
17. Hendzel MJ,Wei Y,Mancini MA,Van Hooser A,Ranalli T,Brinkley BR,Bazett-Jones DP,Allis CD.Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation.Chromosoma. 1997;106:348-60.
18. Nicholson DW,Ali A,Thornberry NA,Vaillancourt JP,Ding CK,Gallant M,Gareau Y,Griffin PR,Labelle M,Lazebnik YA,Munday NA,Raju SM,Smulson ME,Yamin TT,Yu VL,Miller DK.Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.Nature. 1995;376:37-43.
19. Lippke JA,Gu Y,Sarnecki C,Caron PR,Su MS.Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32.J Biol Chem. 1996;271:1825-8.
20. Fernandes-Alnemri T,Takahashi A,Armstrong R,Krebs J,Fritz L,Tomaselli KJ,Wang L,Yu Z,Croce CM,Salveson G,Earnshaw WC,Litwack G,Alnemri ES.Mch3, a novel human apoptotic cysteine protease highly related to CPP32.Cancer Res. 1995;55:6045-52.
21. Metge B,Ofori-Acquah S,Stevens T,Balczon R.Stat3 activity is required for centrosome duplication in chinese hamster ovary cells.J Biol Chem. 2004;279:41801-6.
22. Wittmann J,Hol EM,Jack HM.hUPF2 silencing identifies physiologic substrates of mammalian nonsense-mediated mRNA decay.Mol Cell Biol. 2006;26:1272-87.
23. Weischenfeldt J,Damgaard I,Bryder D,Theilgaard-Monch K,Thoren LA,Nielsen FC,Jacobsen SEW,Nerlov C,Porse BT.NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements.Genes Dev. 2008;22:1381-96.
24. Wittkopp N,Huntzinger E,Weiler C,Sauliere J,Schmidt S,Sonawane M,Izaurralde E.Nonsense-mediated mRNA decay effectors are essential for zebrafish embryonic development and survival.Mol Cell Biol. 2009;29:3517-28.
25. Tarpey PS,Raymond FL,Nguyen LS,Rodriguez J,Hackett A,Vandeleur L,Smith R,Shoubridge C,Edkins S,Stevens C,O'Meara S,Tofts C,Barthorpe S,Buck G,Cole J,Halliday K,Hills K,Jones D,Mironenko T,Perry J,Varian J,West S,Widaa S,Teague J,Dicks E,Butler A,Menzies A,Richardson D,Jenkinson A,Shepherd R,Raine K,Moon J,Luo Y,Parnau J,Bhat S,Gardner A,Corbett M,Brooks D,Thomas P,Parkinson-Lawrence E,Porteous ME,Warner JP,Sanderson T,Pearson P,Simensen RJ,Skinner C,Hoganson G,Superneau D,Wooster R,Bobrow M,Turner G,Stevenson RE,Schwartzn CE,Futreal PA,Srivastava AK,Stratton MR,Gécz J.Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation.Nat Genet. 2007;39:1127-33.
26. Azzalin CM,Lingner J.The human RNA surveillance factor UPF1 is required for S phase progression and genome stability.Curr Biol. 2006;16:433-9.
27. Brumbaugh KM,Otterness DM,Geisen C,Oliveira V,Brognard J,Li X,Lejeune F,Maquat LE,Abraham RT.The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells.Mol Cell. 2004;14:585-98.
28. Gehen SC,Staversky RJ,Bambara RA,Keng PC,O'Reilly MA.hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress.Oncogene. 2008;27:4065-74.
29. Xia QS,Ishigaki Y,Zhao X,Shimasaki T,Nakajima H,Nakagawa H,Takegami T,Chen Z,Motoo Y.Human SMG-1 is involved in gemcitabine-induced primary microRNA-155/BIC up-regulation in human pancreatic cancer PANC-1 cells.Pancreas. 2011;40:55-60.
30. Weiderhold KN,Randall-Hlubek DA,Polin LA,Hamel E,Mooberry SL.CB694, a novel antimitotic with antitumor activities.Int J Cancer. 2006;118:1032-40.
31. Jordan MA,Wilson L.Microtubules as a target for anticancer drugs.Nature Rev Cancer. 2004;4:253-65.